Table 1 Clinical and Demographic Characteristics of the Study Subjects.
From: Structural Implications of Mutations Conferring Rifampin Resistance in Mycobacterium leprae
Si. No. | Characteristics | Types | Relapsed/MDT-Non-Respondent Leprosy Cases | |
|---|---|---|---|---|
Number | % | |||
1 | Gender | Male | 24 | 68.57 |
Female | 11 | 31.43 | ||
2 | Age | 1–15 | 0 | 0.00 |
16–30 | 7 | 20.00 | ||
31–50 | 14 | 40.00 | ||
>50 | 14 | 40.00 | ||
3 | WHO Classification | PB | 0 | 0.00 |
MB | 35 | 100.00 | ||
4 | Ridley Jopling Classification | Indeterminate (IND) | 0 | 0.00 |
TT | 0 | 0.00 | ||
BT | 5 | 14.29 | ||
BB | 2 | 5.71 | ||
BL | 4 | 11.43 | ||
LL | 24 | 68.57 | ||
5 | Current Bacteriological Index (BI) | Negative | 3 | 8.57 |
1–2 | 7 | 20.00 | ||
2.25–4 | 14 | 40.00 | ||
4.25–6 | 11 | 31.43 | ||
6 | MDT Duration | 12 Months | 18 | 51.43 |
24 Months | 10 | 28.57 | ||
>24 Months | 7 | 20.00 | ||
7 | Clinical Status | Relapse | 13 | 37.14 |
Non-Respondents | 22 | 62.86 | ||
8 | Duration between initial disease/treatment episode and relapse | 0–3 Years | 23 | 65.71 |
4–10 Years | 7 | 20.00 | ||
>10 Years | 5 | 14.29 | ||
